Glucose-6-phosphate dehydrogenase deficiency genotypes and allele frequencies in the Kavango and Zambezi regions of northern Namibia

Trans R Soc Trop Med Hyg. 2019 Aug 1;113(8):483-488. doi: 10.1093/trstmh/trz035.

Abstract

Background: Namibia has made significant gains in the fight against malaria, with a target of elimination by 2023. We examined the genotype and allele frequencies of glucose-6-phosphate dehydrogenase (G6PD) deficiency to inform decisions on primaquine use, as we recently detected clusters of Plasmodium ovale curtisi in Kavango.

Methods: A multistaged cross-sectional sampling method was used to enrol 212 children 2-9 y of age from schools and clinics in the Okavango and Zambezi regions of northern Namibia. Genotypes for the 202 G→A and 376 A→G mutations were assigned by polymerase chain reaction restriction fragment length polymorphism.

Results: Of the 212 subjects enrolled, genotypes were available for 210, made up of 61 males and 149 females. G6PD-deficient males (hemizygotes) and females (homozygotes) constituted 3.27% (2/61) and 0.0% (0/149), respectively. Female heterozygotes (AA- and BA-) constituted 10.07% (15/149), while G6PD wild-type males (with A or B haplotype) and females (with AA, BB or AB haplotypes) consisted of 96.72% (59/61) and 89.93% (134/149), respectively. The A-, A and B allele frequencies were 0.0474, 0.3036 and 0.6490, respectively. Hardy-Weinberg equilibrium tests for female genotype frequencies did not show deviation (p=0.29).

Conclusions: The frequency of G6PD deficiency alleles in males in the Kavango and Zambezi regions of northern Namibia constitute 3.27%, a first report to inform policy on primaquine role out.

Keywords: G6PDd alleles; Kavango; Namibia; Zambezi; genotypes; primaquine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antimalarials / administration & dosage
  • Antimalarials / adverse effects
  • Child
  • Child, Preschool
  • Cross-Sectional Studies
  • Female
  • Gene Frequency*
  • Genotype
  • Glucosephosphate Dehydrogenase
  • Glucosephosphate Dehydrogenase Deficiency / drug therapy
  • Glucosephosphate Dehydrogenase Deficiency / epidemiology
  • Glucosephosphate Dehydrogenase Deficiency / genetics*
  • Haplotypes
  • Humans
  • Infant
  • Malaria / drug therapy
  • Male
  • Mutation
  • Namibia / epidemiology
  • Primaquine / administration & dosage
  • Primaquine / adverse effects

Substances

  • Antimalarials
  • Glucosephosphate Dehydrogenase
  • Primaquine